Cargando…
Time in range: a new parameter to evaluate blood glucose control in patients with diabetes
The International Consensus in Time in Range (TIR) was recently released and defined the concept of the time spent in the target range between 70 and 180 mg/dL while reducing time in hypoglycemia, for patients using Continuous Glucose Monitoring (CGM). TIR was validated as an outcome measures for cl...
Autores principales: | Gabbay, Monica Andrade Lima, Rodacki, Melanie, Calliari, Luis Eduardo, Vianna, Andre Gustavo Daher, Krakauer, Marcio, Pinto, Mauro Scharf, Reis, Janice Sepúlveda, Puñales, Marcia, Miranda, Leonardo Garcia, Ramalho, Ana Claudia, Franco, Denise Reis, Pedrosa, Hermelinda Pedrosa Cordeiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076978/ https://www.ncbi.nlm.nih.gov/pubmed/32190124 http://dx.doi.org/10.1186/s13098-020-00529-z |
Ejemplares similares
-
Using trend arrows in continuous glucose monitoring systems for insulin adjustment in clinical practice: Brazilian Diabetes Society Position Statement
por: Rodacki, M., et al.
Publicado: (2021) -
Real-world flash glucose monitoring in Brazil: can sensors make a difference in diabetes management in developing countries?
por: Calliari, Luis Eduardo P., et al.
Publicado: (2020) -
Results of glycated hemoglobin during treatment with insulin analogues dispensed in the public health system of Federal District in Brazil
por: Leite, Eliziane Brandão, et al.
Publicado: (2015) -
Insulin Injection Technique Questionnaire: results of an international study comparing Brazil, Latin America and World data
por: Calliari, Luis Eduardo, et al.
Publicado: (2018) -
Decentralized COVID-19 measures in Brazil were ineffective to protect people with diabetes
por: Ugliara Barone, Mark Thomaz, et al.
Publicado: (2020)